1. 1Laboratory of Molecular Biology, National Institutes of Health, Bethesda, MD
2. 2Department of Hematology, CHU de Nantes, Nantes, France
3. 3Division of Cancer Medicine, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
4. 4Department of Haematology and Phase 1 Unit, Rigshospitalet, Copenhagen, Denmark
5. 5Gustave Roussy Cancer Institute, Villejuif, France
6. 6Centre Léon Bérard, Lyon, France
7. 7Department of Medicine, UCLA, Los Angeles, CA
8. 8Department of Internal Medicine II (Oncology Center), University Medical Center Hamburg-Eppendorf, Hamburg, Germany
9. 9University of Heidelberg, Heidelberg, Germany
10. 10Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
11. 11Internal Medicine V: Hematology & Oncology, Medical University Innsbruck, Innsbruck, Austria
12. 12Oncotyrol–Center for Personalized Cancer Medicine, Innsbruck, Austria
13. 13University Hospital Vrije Universiteit Brussel, Brussels, Belgium
14. 14Global Drug Development, Oncology Development Unit, Novartis Pharmaceuticals Corporation, East Hanover, NJ
15. 15Global Drug Development, Oncology Development Unit, Novartis Pharma AG, Basel, Switzerland
16. 16Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX